Biocon Biologics successfully integrates acquired biosimilars business across 120 countries Read more
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData Read more
‘Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets’ Read more